Search Results
Dr. Penson on Biomarkers of Response to PARP Inhibitors in Ovarian Cancer
Dr. Penson on Research With PARP Inhibitors in Ovarian Cancer
Dr. Penson on Re-Challenging With PARP Inhibition in Ovarian Cancer
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
Dr. Coleman on the Utility of Biomarkers for Precision Medicine in Ovarian Cancer
Dr. Matulonis on CPS as a Potential Biomarker in Advanced Recurrent Ovarian Cancer
PARP inhibitor combo shows early promise for patients with and without BRCA mutations
Updates in Treatment of Ovarian Cancer: PARP Inhibitors
Recurrent Ovarian Cancer: QUADRA Trial
Treatment After Third-Line Therapy in Ovarian Cancer
Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the C...
Dr. Penson on Questions Regarding Next-Generation AR Inhibitors in Prostate Cancer
